Search

Your search keyword '"Serio I."' showing total 120 results

Search Constraints

Start Over You searched for: Author "Serio I." Remove constraint Author: "Serio I."
120 results on '"Serio I."'

Search Results

1. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

2. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

3. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

4. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

5. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

6. Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register

7. Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients

8. Corrigendum to 'Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study' [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001)

9. Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients

10. Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients

11. Pattern of in-hospital changes in drug use in the older people from 2010 to 2016

12. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

13. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study

14. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

16. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

17. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

18. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia

19. Prevalence and Determinants of the Use of Lipid-Lowering Agents 3 in a Population of Older Hospitalized Patients: the Findings 4 from the REPOSI (REgistro POliterapie Societa' Italiana di 5 Medicina Interna) Study

20. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

21. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

22. IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: a multicenter prospective trial in Italy

24. Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study

25. Risk factors for hospital readmission of elderly patients

26. Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients

27. Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study

28. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly

29. Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

30. Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older

31. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients

32. Liver stiffness fibrosis thresholds of Fibroscan cannot be adopted by all new elastography machines: A comparative study

33. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients

34. Association syndrome lymphohystiocytaire (HLH) et lupus systémique : étude multicentrique française de 103 épisodes chez 89 patients adultes

35. The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy

36. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study

37. Efficacy of superselective TACE in treatment of HCC

38. OP0184 Clinical Spectrum and Therapeutic Management of Systemic Lupus Erythematosus-Associated Macrophage Activation Syndrome. Data from A French Nationwide Study of 81 Episodes in 67 Adult Patients

39. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice

40. Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study

41. PS-152 - IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: a multicenter prospective trial in Italy

42. IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: A multicenter prospective trial in Italy

43. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation

44. Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010

45. Heart failure and chronic kidney disease in a registry of internal medicine wards

46. Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI

48. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

Catalog

Books, media, physical & digital resources